148 related articles for article (PubMed ID: 6870377)
1. Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA
Ann Surg; 1983 Aug; 198(2):192-9. PubMed ID: 6870377
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a subset of human natural killer cells that express OKM1 but lack HNK-1 (Leu-7) antigens.
Marolda R; Tilden AB; Abo T; Dougherty PA; Balch CM
Scand J Immunol; 1984 Sep; 20(3):261-5. PubMed ID: 6238402
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
Abo T; Miller CA; Balch CM
Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
6. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
Tilden AB; Abo T; Balch CM
J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells in systemic lupus erythematosus. Abnormal numbers and functional immaturity of HNK-1+ cells.
Egan ML; Mendelsohn SL; Abo T; Balch CM
Arthritis Rheum; 1983 May; 26(5):623-9. PubMed ID: 6687804
[TBL] [Abstract][Full Text] [Related]
8. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
Abo T; Roder JC; Abo W; Cooper MD; Balch CM
J Clin Invest; 1982 Jul; 70(1):193-7. PubMed ID: 7085883
[TBL] [Abstract][Full Text] [Related]
9. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
Abo T; Balch CM
J Immunol; 1981 Sep; 127(3):1024-9. PubMed ID: 6790607
[TBL] [Abstract][Full Text] [Related]
10. Subpopulation analysis of human granular lymphocytes: associations with age, gender and cytotoxic activity.
Tilden AB; Grossi CE; Itoh K; Cloud GA; Dougherty PA; Balch CM
Nat Immun Cell Growth Regul; 1986; 5(2):90-9. PubMed ID: 3724768
[TBL] [Abstract][Full Text] [Related]
11. Definite spontaneous cell-mediated cytotoxicity and HNK-1 cells in the human large intestine.
Chiba M; Ohta H; Masamune O; Yoshida Y
Gastroenterol Jpn; 1986 Dec; 21(6):584-93. PubMed ID: 3552847
[TBL] [Abstract][Full Text] [Related]
12. Natural killer-cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK-1 (LEU-7) and B73.1.
Fujimiya Y; Bakke A; Chang WC; Linker-Israeli M; Udis B; Horwitz D; Pattengale PK
Int J Cancer; 1986 May; 37(5):639-49. PubMed ID: 3457769
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
14. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies].
Graul A; Orfanos CE
Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439
[TBL] [Abstract][Full Text] [Related]
15. In vitro propagation of cultured human natural killer cells expressing the HNK-1 differentiation antigen and spontaneous cytotoxic function.
Abo T; Balch CM
Eur J Immunol; 1983 May; 13(5):383-9. PubMed ID: 6406236
[TBL] [Abstract][Full Text] [Related]
16. Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody.
Abo T; Cooper MD; Balch CM
J Exp Med; 1982 Jan; 155(1):321-6. PubMed ID: 7054358
[TBL] [Abstract][Full Text] [Related]
17. Natural killing (NK) potential of cord blood lymphocytes.
Toder V; Durdana A; Elrad H; Gleicher N
J Clin Lab Immunol; 1985 May; 17(1):29-32. PubMed ID: 4045996
[TBL] [Abstract][Full Text] [Related]
18. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.
Phillips JH; Lanier LL
J Exp Med; 1985 Jun; 161(6):1464-82. PubMed ID: 3159818
[TBL] [Abstract][Full Text] [Related]
19. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
20. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
Rumpold H; Kraft D; Gastl G; Huber C
Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
